Variations in start dates for chemotherapy, radiotherapy increase risk of death for NSCLC patients

Concurrent chemoradiation therapy is the standard of care for patients with inoperable non-small cell lung cancer (NSCLC), but starting the dual treatments more than three days apart from each other can result in poorer overall survival and an 8 percent increased risk of death, according to research published in Clinical Lung Cancer this summer.

Siemens Healthineers launches Acuson Sequoia to address industry challenges in ultrasound imaging

Siemens Healthineers has announced the launch of its new ultrasound system, the Acuson Sequoia. The new Acuson Sequoia, a general imaging ultrasound system, was developed in response to one of the most prevalent challenges in ultrasound imaging today: the imaging of different sized patients with consistency and clarity.